MIA Protein (Transcript Variant 1)
Kurzübersicht für MIA Protein (Transcript Variant 1) (ABIN2725964)
Target
Alle MIA Proteine anzeigenProtein-Typ
Biologische Aktivität
Spezies
Quelle
Applikation
Reinheit
-
-
Proteineigenschaft
- Transcript Variant 1
-
Spezifität
- Optimal preservation of protein structure, post-translational modifications and functions.
-
Produktmerkmale
-
- Recombinant human MIA (transcript variant 1) protein expressed in E. coli.
- Produced with end-sequenced ORF clone
- Tested for bioactivity.
-
Endotoxin-Niveau
- Endotoxin level is <0.1 ng/μg of protein (<1EU/μg).
-
Biological Activity Comment
- ED50 was determined by the dose-dependant proliferation of the human A375 melanoma cell line. The expected ED50 for this effect is 4-6ug/mL.
-
-
Möchten Sie weitere Optionen für dieses Protein ?
!Entdecken Sie unsere vordefinierten maßgeschneiderten Proteine und Proteinservices!Ihr Projekt erfordert weitere Anpassungen? Kontaktieren Sie uns und entdecken Sie unsere maßgeschneiderten Proteinlösungen
-
-
-
Applikationshinweise
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays
Protein-protein interaction
In vitro biochemical assays and cell-based functional assays -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- Lyophilized from a 0.2 μM filtered solution of 20 mM phosphate buffer,100 mM NaCl, pH 7.2
-
Handhabung
- Resuspend the protein in the desired concentration in proper buffer
-
Lagerung
- -80 °C
-
Informationen zur Lagerung
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
-
- MIA (Melanoma Inhibitory Activity (MIA))
-
Andere Bezeichnung
- Mia
-
Hintergrund
- Elicits growth inhibition on melanoma cells in vitro as well as some other neuroectodermal tumors, including gliomas. [UniProtKB/Swiss-Prot Function]
-
Molekulargewicht
- 12.2 kDa
-
NCBI Accession
- NP_006524
Target
-